A Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients

Status:
Terminated

Trial end date:
2021-04-26

Target enrollment:

Participant gender:

Open-label, extension study to evaluate the safety and efficacy of combination therapy and its effect on sustained viral response biomarkers.

Phase 2

Assembly Biosciences

Entecavir
Tenofovir